1. Home
  2. TNON vs EVGN Comparison

TNON vs EVGN Comparison

Compare TNON & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.91

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.31

Market Cap

5.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNON
EVGN
Founded
2012
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
5.1M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
TNON
EVGN
Price
$0.91
$0.31
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
95.4K
★ 180.8K
Earning Date
11-12-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.90
N/A
EPS
N/A
★ N/A
Revenue
★ $3,944,000.00
N/A
Revenue This Year
$44.38
N/A
Revenue Next Year
$39.49
$81.06
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 20.35
N/A
52 Week Low
$0.96
$0.25
52 Week High
$40.95
$1.26

Technical Indicators

Market Signals
Indicator
TNON
EVGN
Relative Strength Index (RSI) 22.15 41.43
Support Level N/A $0.25
Resistance Level $4.18 $0.41
Average True Range (ATR) 0.17 0.05
MACD -0.02 0.00
Stochastic Oscillator 4.65 31.35

Price Performance

Historical Comparison
TNON
EVGN

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: